Virilizing ovarian tumor of low malignant potential associated with antecedent tamoxifen use for breast cancer
- PMID: 9570983
- DOI: 10.1006/gyno.1998.4935
Virilizing ovarian tumor of low malignant potential associated with antecedent tamoxifen use for breast cancer
Abstract
A patient is described who was treated with tamoxifen for breast cancer and developed an androgen-producing ovarian tumor of low malignant potential, which itself is a rare condition. Clinically overt virilism was leading to the diagnosis and promptly improved after surgical removal of the tumor. A causal relationship between tamoxifen use and the tumor is discussed on the basis of the known tumor-inducing potential of tamoxifen.
Similar articles
-
Granulosa cell tumor of the ovary associated with antecedent tamoxifen use.Obstet Gynecol. 1994 Oct;84(4 Pt 2):717-9. Obstet Gynecol. 1994. PMID: 9205462 Review.
-
Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.Gynecol Oncol. 2004 Oct;95(1):264-6. doi: 10.1016/j.ygyno.2004.06.039. Gynecol Oncol. 2004. PMID: 15385144
-
Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen.Gynecol Oncol. 1996 Jan;60(1):54-8. doi: 10.1006/gyno.1996.0011. Gynecol Oncol. 1996. PMID: 8557228 Clinical Trial.
-
Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.Gynecol Oncol. 1999 Dec;75(3):509-13. doi: 10.1006/gyno.1999.5604. Gynecol Oncol. 1999. PMID: 10600318
-
The nature of tamoxifen action in the control of female breast cancer.In Vivo. 2001 Jul-Aug;15(4):319-25. In Vivo. 2001. PMID: 11695224 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical